ArieStudio/Shutterstock.com
Jhoots Pharmacy has entered administration with the administrator’s statement outlining £19m debt.
A Companies House filing for administration was published on 12 January 2026, relating to a number of companies trading under the name of Jhoots Pharmacy, which is owned by Sarbjit Jhooty.
The statement of administrator’s proposal shows that in December 2023, the company reported a £5m pre-tax loss against a £3m profit. It also owed £19.6m in debt at that point.
The filing said: “Losses appear to be driven by a substantial reduction in gross profit margins and significant increases in overheads.
“The group has been subject to the financial challenges affecting the industry, which was exacerbated by the purchase of additional pharmacies in 2023 without the appropriate structures in place to maintain operations.”
“Microeconomic challenges, such as increased staff costs and higher rents, as well as stagnated NHS pricings and increased drug costs, have directly contributed to the current financial performance resulting in all sites being closed,” it added.
The filing follows ongoing issues with the chain, including unexpected closures, poor service and allegations that locum staff have not been paid.
In a separate statement of administrators proposals, published on the Companies House website on 7 January 2026, SNJ Health, which operated more than 60 Jhoots branches, also filed for administration.
According to the statement, the company reported a loss of £1.2m in the year from August 2024 to July 2025, although it warned that this figure had not been verified for accuracy.
“Dispensing volumes across the group had collapsed from an average of 208,272 items dispensed in December 2024 to 15,260 items dispensed in September 2025,” the statement added.
It also said that employee wages had not been paid since July 2025 and landlord enforcement action had taken place.
“There had been significant negative press coverage regarding the group’s pharmacies, which resulted in adverse NHS attention and put the pharmacy licences themselves at risk. The NHS had begun disciplinary action against companies within the group in relation to pharmacy non-performance,” the statement said.
The administrator’s statement also highlighted that these pharmacies were sold to Allied Pharmacies in a “pre-pack sale” for £4.75m.
In October 2025, Sarbjit Jhooty exclusively told The Pharmaceutical Journal that he was selling and remortgaging stores in order to pay staff wages and rent. The sell-off included disposing of “30 stores”, with Jhooty adding that he would sell more if necessary.
In November, 2025, Allied Pharmacies announced that it had taken over 60 Jhoots branches, while in December 2025, the multiple announced it had acquired a further 68 branches.
Also in December 2025, Manjit Jhooty — who owns 21 pharmacies under the Jhoots brand — announced he was rebranding his store portfolio to JHL Pharmacy, after “other pharmacy operators trading as Jhoots Pharmacy have caused significant and irreparable damage to the brand name”.
In an update on Jhoots issues, published on 12 January 2026, the Pharmacists’ Defence Association (PDA) said that it had contacted the General Pharmaceutical Council (GPhC) regarding “apparently out-of-date information” on the regulator’s website.
While companies under the Jhoots brand had entered administration in January 2026 “at time of writing the GPhC register says those businesses still own around one hundred branches despite many of them being simultaneously listed on Allied Pharmacies website”, the PDA said.
The PDA added that locum members “continue to pursue debts and inaccurate information … can add extra difficulty in tracking down who exactly is responsible in an already complex structure of businesses”.
In November 2025, prime minister Keir Starmer told Parliament that ministers were “working speedily to consider how to strengthen regulation” of pharmacies, in light of the situation regarding Jhoots Pharmacy.
